Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic <it>Caenorhabditis elegans</it>
<p>Abstract</p> <p>Background</p> <p>Epidemiological studies have associated estrogen replacement therapy with a lower risk of developing Alzheimer's disease, but a higher risk of developing breast cancer and certain cardiovascular disorders. The neuroprotective ef...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2005-08-01
|
| Series: | BMC Neuroscience |
| Online Access: | http://www.biomedcentral.com/1471-2202/6/54 |